Asabys is a Europe-based venture capital firm dedicated exclusively to life sciences, biotech, and healthcare innovation, investing from early clinical stages through growth. The firm brings deep expertise in drug development, regulatory pathways, and pharma partnerships. Asabys is relevant only to founders operating in regulated biomedical domains; general tech or digital health without clinical depth will not qualify. Founder engagement is long-term and rigorous, not fast-moving seed-style investing.